FDAFebruary 7, 2017drug

Glipizide 2.5 mg ER Tablets, Manufactured by Watson Laboratories, Inc., Parsippany, NJ 07054, Repackaged by RemedyRepack, Indiana, PA 15701, NDC 52125-0764-02

Official recall recorded by the U.S. Food & Drug Administration.

The hazard

Failed Dissolution Specifications

What to do

FDA enforcement status: Terminated

Brands named

remedyrepack

UPCs

0059109003052125076402

Recall history

Other federal recalls tied to the same brand — a factual pattern, straight from the source data.

Own something like this?

AllClear screens your whole list against every CPSC, FDA, USDA and NHTSA recall — and tells you the day a new one names something you own.

Start free — 200 items, no card →